Looking back, thinking ahead: industry leaders talk trends
Experts from a variety of research and drug development organizations share their thoughts on highlights from 2020, and predict what 2021 might hold.
Archives for December 16, 2020
Researchers ‘must embrace the change’ in the year ahead: PRA
The head of the CRO’s Global Center of Excellence for Decentralized Clinical Trial Strategy outlines key developments in 2020, and keys to success in 2021.
2020 was ‘the year our industry got it right’: pharma veteran
William Carson says while the past year was full of challenges, embracing AI and other advanced technology led to impressive progress and opportunity.
Despite roadblocks, demand for innovative treatments persists: IQVIA
Look for advances in decentralized trials, data collection, remote monitoring and other areas, says a leader from the research tech solutions firm.
Data explosion leads to opportunities, obstacles: ACD/Labs
A representative from the small-molecule solutions company explains how the ever-increasing mountain of life-sciences data has impacted drug development.